144 related articles for article (PubMed ID: 38127222)
21. Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.
Yang B; Liao GQ; Wen XF; Chen WH; Cheng S; Stolzenburg JU; Ganzer R; Neuhaus J
J Zhejiang Univ Sci B; 2017 Nov.; 18(11):921-933. PubMed ID: 29119730
[TBL] [Abstract][Full Text] [Related]
22. Successful combination of benchtop nuclear magnetic resonance spectroscopy and chemometric tools: A review.
Galvan D; de Aguiar LM; Bona E; Marini F; Killner MHM
Anal Chim Acta; 2023 Sep; 1273():341495. PubMed ID: 37423658
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia.
Amante E; Cerrato A; Alladio E; Capriotti AL; Cavaliere C; Marini F; Montone CM; Piovesana S; Laganà A; Vincenti M
Sci Rep; 2022 Mar; 12(1):4361. PubMed ID: 35288652
[TBL] [Abstract][Full Text] [Related]
24. Untargeted assignment and automatic integration of
Puig-Castellví F; Alfonso I; Tauler R
Anal Chim Acta; 2017 Apr; 964():55-66. PubMed ID: 28351639
[TBL] [Abstract][Full Text] [Related]
25. Improved classification accuracy in 1- and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation.
Parsons HM; Ludwig C; Günther UL; Viant MR
BMC Bioinformatics; 2007 Jul; 8():234. PubMed ID: 17605789
[TBL] [Abstract][Full Text] [Related]
26. Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer.
Dinges SS; Vandergrift LA; Wu S; Berker Y; Habbel P; Taupitz M; Wu CL; Cheng LL
NMR Biomed; 2019 Oct; 32(10):e4038. PubMed ID: 30609175
[TBL] [Abstract][Full Text] [Related]
27. Classification of Raw Stingless Bee Honeys by Bee Species Origins Using the NMR- and LC-MS-Based Metabolomics Approach.
Razali MTA; Zainal ZA; Maulidiani M; Shaari K; Zamri Z; Mohd Idrus MZ; Khatib A; Abas F; Ling YS; Rui LL; Ismail IS
Molecules; 2018 Aug; 23(9):. PubMed ID: 30154302
[TBL] [Abstract][Full Text] [Related]
28. 1H NMR-based metabonomics for infertility diagnosis in men with varicocele.
Neto FTL; Marques RA; de Freitas Cavalcanti Filho A; Araujo LCN; Lima SVC; Pinto L; Silva RO
J Assist Reprod Genet; 2020 Sep; 37(9):2233-2247. PubMed ID: 32715373
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous detection of multiple inherited metabolic diseases using GC-MS urinary metabolomics by chemometrics multi-class classification strategies.
Yang Q; Xu L; Tang LJ; Yang JT; Wu BQ; Chen N; Jiang JH; Yu RQ
Talanta; 2018 Aug; 186():489-496. PubMed ID: 29784392
[TBL] [Abstract][Full Text] [Related]
30. The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies.
Aggio RB; de Lacy Costello B; White P; Khalid T; Ratcliffe NM; Persad R; Probert CS
J Breath Res; 2016 Feb; 10(1):017106. PubMed ID: 26865331
[TBL] [Abstract][Full Text] [Related]
31. Prostate lesion delineation from multiparametric magnetic resonance imaging based on locality alignment discriminant analysis.
Lin M; Chen W; Zhao M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Chow TWS; Ward AD; Chiu B
Med Phys; 2018 Oct; 45(10):4607-4618. PubMed ID: 30153334
[TBL] [Abstract][Full Text] [Related]
32. NMR metabolic analysis of samples using fuzzy K-means clustering.
Cuperlović-Culf M; Belacel N; Culf AS; Chute IC; Ouellette RJ; Burton IW; Karakach TK; Walter JA
Magn Reson Chem; 2009 Dec; 47 Suppl 1():S96-104. PubMed ID: 19731396
[TBL] [Abstract][Full Text] [Related]
33. NMR-Based Prostate Cancer Metabolomics.
Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
[TBL] [Abstract][Full Text] [Related]
34. Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.
Deng L; Gu H; Zhu J; Nagana Gowda GA; Djukovic D; Chiorean EG; Raftery D
Anal Chem; 2016 Aug; 88(16):7975-83. PubMed ID: 27437783
[TBL] [Abstract][Full Text] [Related]
35. Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine.
Cerrato A; Bedia C; Capriotti AL; Cavaliere C; Gentile V; Maggi M; Montone CM; Piovesana S; Sciarra A; Tauler R; Laganà A
Anal Chim Acta; 2021 May; 1158():338381. PubMed ID: 33863412
[TBL] [Abstract][Full Text] [Related]
36. A metabolomic approach for diagnosis of experimental sepsis.
Izquierdo-García JL; Nin N; Ruíz-Cabello J; Rojas Y; de Paula M; López-Cuenca S; Morales L; Martínez-Caro L; Fernández-Segoviano P; Esteban A; Lorente JA
Intensive Care Med; 2011 Dec; 37(12):2023-32. PubMed ID: 21976186
[TBL] [Abstract][Full Text] [Related]
37. MetaFIND: a feature analysis tool for metabolomics data.
Bryan K; Brennan L; Cunningham P
BMC Bioinformatics; 2008 Nov; 9():470. PubMed ID: 18986526
[TBL] [Abstract][Full Text] [Related]
38. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
39. A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding.
Gromski PS; Muhamadali H; Ellis DI; Xu Y; Correa E; Turner ML; Goodacre R
Anal Chim Acta; 2015 Jun; 879():10-23. PubMed ID: 26002472
[TBL] [Abstract][Full Text] [Related]
40. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
